Indredavik B - Search Results

1

Short- and long-term outcome of constraint-induced movement therapy after stroke: a randomized controlled feasibility trial.

Dahl AE, Askim T, Stock R, Langørgen E, Lydersen S, Indredavik B. Dahl AE, et al. Among authors: indredavik b. Clin Rehabil. 2008 May;22(5):436-47. doi: 10.1177/0269215507084581. Clin Rehabil. 2008. PMID: 18441040 Clinical Trial.

2

Benefit of a stroke unit: a randomized controlled trial.

Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I. Indredavik B, et al. Stroke. 1991 Aug;22(8):1026-31. doi: 10.1161/01.str.22.8.1026. Stroke. 1991. PMID: 1866749 Clinical Trial.

3

Stroke unit treatment. Long-term effects.

Indredavik B, Slørdahl SA, Bakke F, Rokseth R, Håheim LL. Indredavik B, et al. Stroke. 1997 Oct;28(10):1861-6. doi: 10.1161/01.str.28.10.1861. Stroke. 1997. PMID: 9341685 Clinical Trial.

4

Stroke unit treatment improves long-term quality of life: a randomized controlled trial.

Indredavik B, Bakke F, Slørdahl SA, Rokseth R, Håheim LL. Indredavik B, et al. Stroke. 1998 May;29(5):895-9. doi: 10.1161/01.str.29.5.895. Stroke. 1998. PMID: 9596231 Clinical Trial.

5

Benefit of an extended stroke unit service with early supported discharge: A randomized, controlled trial.

Indredavik B, Fjaertoft H, Ekeberg G, Løge AD, Mørch B. Indredavik B, et al. Stroke. 2000 Dec;31(12):2989-94. doi: 10.1161/01.str.31.12.2989. Stroke. 2000. PMID: 11108761 Clinical Trial.

6

Evaluation of an extended stroke unit service with early supported discharge for patients living in a rural community. A randomized controlled trial.

Askim T, Rohweder G, Lydersen S, Indredavik B. Askim T, et al. Among authors: indredavik b. Clin Rehabil. 2004 May;18(3):238-48. doi: 10.1191/0269215504cr752oa. Clin Rehabil. 2004. PMID: 15137554 Clinical Trial.

7

Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation.

Indredavik B, Rohweder G, Lydersen S. Indredavik B, et al. J Intern Med. 2005 Aug;258(2):133-44. doi: 10.1111/j.1365-2796.2005.01512.x. J Intern Med. 2005. PMID: 16018790 Free article.

8

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E; SCAST Study Group. Sandset EC, et al. Lancet. 2011 Feb 26;377(9767):741-50. doi: 10.1016/S0140-6736(11)60104-9. Lancet. 2011. PMID: 21316752 Clinical Trial.

9

Multimodal individualised intervention to prevent functional decline after stroke: protocol of a randomised controlled trial on long-term follow-up after stroke (LAST-long).

Askim T, Hokstad A, Bergh E, Døhl Ø, Ellekjær H, Ihle-Hansen H, Indredavik B, Leer ASM, Lydersen S, Saltvedt I, Seljeseth Y, Thommessen B. Askim T, et al. Among authors: indredavik b. BMJ Open. 2023 May 10;13(5):e069656. doi: 10.1136/bmjopen-2022-069656. BMJ Open. 2023. PMID: 37164457 Free PMC article.

10

Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important?

Indredavik B, Bakke F, Slordahl SA, Rokseth R, Hâheim LL. Indredavik B, et al. Stroke. 1999 May;30(5):917-23. doi: 10.1161/01.str.30.5.917. Stroke. 1999. PMID: 10229720 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page